Raymond James analyst Pavel Molchanov maintains Itron (NASDAQ:ITRI) with a Strong Buy and lowers the price target from $72 to $68.
‘North Carolina Senate Approves Medical Marijuana Regulatory Appointment As House Leader Says ‘Heavy-Handed’ Tactics Not Helping Legalization’s Fate’ – Marijuana Moment
https://www.marijuanamoment.net/north-carolina-senate-approves-medical-marijuana-regulatory-appointment-as-house-leader-says-heavy-handed-tactics-not-helping-legalizations-fate/
A Republican North Carolina senator is
